# Critical Evaluation of Subcellular Compartmentalization Biomarker Hypotheses
## Hypothesis 1: Mitochondrial Compartment-Specific Proteostasis Reporter
### Weak Links
- **Reporter ambiguity problem**: If mitochondrial import machinery is impaired (the very pathology being measured), the MTS-dGFP reporter may fail to localize to mitochondria at all—generating a false-negative that is indistinguishable from severe pathology. This creates a ceiling effect where the biomarker cannot report beyond complete import failure.
- **Indirect mechanism**: TOM20/TOM40 dysfunction does not constitute "compartmentalization" per se; it is a fundamental bioenergetic organelle defect. The logical leap from organelle dysfunction to *subcellular compartmentalization* failure is not rigorously defended.
- **CHOP promoter confound**: The stress-responsive promoter introduces a layer of complexity that confounds interpretation—is nuclear translocation of an *alternative* fluorescent protein measuring compartmentalization or simply cellular stress?
### Counter-Evidence
- ALS-linked TOM40 mutations (PMID: 30209046) show mitochondrial dysfunction, but this is **downstream** of TDP-43 aggregation and is not compartment-specific—mitochondrial defects occur globally in affected neurons.
- TOMM20 immunoreactivity as biomarker (PMID: 31196453) measures protein abundance, not import *fidelity*—it cannot distinguish functional from non-functional import capacity.
- Axonal mitochondrial defects in AD models (PMID: 27545678) represent a well-established endpoint but are a **consequence** of compartmentalization breakdown, not a direct measure of it.
### Falsifying Experiments
1. **Rescue experiment**: Transfect the reporter in cells with TOM40 knocked down—does fluorescence fail to co-localize with mitochondrial dyes? If yes, the reporter is measuring import capacity *only when the system is partially intact*.
2. **Non-MTS control**: Include constitutive cytoplasmic GFP. Ratio of MTS-dGFP:cytoplasmic GFP should remain constant in non-pathological conditions—this internal control is absent from the design.
3. **Single-cell correlation**: Cryo-EM of import pores in the *same cells* used for imaging will test whether morphological correlates exist—without this, the ratiometric imaging remains unanchored to ultrastructure.
### Revised Confidence: **0.45** (from 0.68)
---
## Hypothesis 2: Synaptic-Primary Cilium Shared Signaling Axis
### Weak Links
- **Cilium-neuron translation gap**: Primary cilia are primarily studied in dividing cells and select specialized neurons (olfactory, ependymal). The evidence base for ciliary signaling in cortical or spinal motor neurons—the relevant populations for ALS/AD—is thin. Citations (PMID: 31138801, 29712963) concern Huntington's disease and neurodevelopmental disorders, not adult-onset neurodegeneration.
- **FRET sensor compartmentalization**: The FRET sensors (Epac1-camps) are targeted to ciliary vs. synaptic compartments via ARL13B and PSD95 anchors. It is unclear whether these sensors perturb the compartments they are meant to measure—overexpression of ciliary proteins can disrupt cilium architecture.
- **SMO agonist validation problem**: Pharmacological challenge with smoothened (SMO) agonist tests "reserve capacity" but does not directly measure whether compartmentalization has been restored by a therapeutic. This measures pathway responsiveness, not structural compartmentalization integrity.
### Counter-Evidence
- The cited synaptic polarity cAMP paper (PMID: 28335004) does not establish that cAMP gradients *definitively require* intact ciliary signaling—this is a logical inference, not a demonstrated dependency.
- Ciliopathies produce developmental phenotypes; adult-onset neurodegeneration involves distinct mechanisms. The mechanistic link between developmental ciliary defects and progressive adult neuronal dysfunction is **unsubstantiated**.
- Dual-FRET in a single axon is technically demanding; sensor cross-talk and bleedthrough between compartments will produce artifactual ratiometric signals.
### Falsifying Experiments
1. **Cilia ablation control**: Chemically ablate primary cilia (via chloral hydrate or IFT88 siRNA) in healthy neurons—do synaptic FRET signals change? If not, the compartments are truly independent and the biomarker design is invalid.
2. **Patient iPSC validation**: The hypothesis explicitly mentions validation in patient-derived neurons, but no patient data are provided. This is essential: show that compartmentalization failure is observed in patient neurons before claiming biomarker utility.
### Revised Confidence: **0.38** (from 0.55)
---
## Hypothesis 3: TDP-43 Phase Separation as Compartmentalization Metric
### Weak Links
- **FRAP kinetics ≠ phase separation state**: FRAP measures protein mobility, which is influenced by viscosity, binding interactions, and crowding—not exclusively by liquid-to-solid transition. A decrease in FRAP recovery could reflect increased transient binding rather than irreversible aggregation.
- **Nuclear import receptor evidence is correlative**: IPO4/IP09 are proposed as modulators, but the cited evidence (PMID: 30540933) shows that importin dysfunction causes TDP-43 mislocalization—this is *import* failure, not a specific defect in the phase separation transition. The therapeutic target is unclear.
- **TDP-43 centricity**: The hypothesis assumes TDP-43 is the primary driver of nuclear-cytoplasmic compartmentalization. Other RNA-binding proteins (FUS, hnRNPA1) show similar behavior—measuring only TDP-43 provides a partial picture.
### Counter-Evidence
- TDP-43 pathology is found in >95% of ALS cases—but this refers to *aggregate formation*, not necessarily impaired phase separation. Solid aggregates may form via distinct mechanisms from liquid-to-solid transitions.
- Phase separation of TDP-43 has been observed by super-resolution (